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1025-35 Gene Polymorphisms of TNF-b and IL-6, but Not TNFoa, 
Are Associated With the Inflammatory Response in 
lechemlc Heart Disease 
Luioi M. Biasucci. Giovanna Liuzzo, Chiara Stranieri, Matted Santamaria, Dominick J. 
Angiolillo, Vittoria Rizzello, Giovanna Di Gianuario, Francesca Ginnetti, Annalisa Porto, 
PierFranco Pignatti, Cardiology, Catholic Universi~ Rome, Italy, Genetics, University of 
Verona, Verona, Italy, 
Background: The multifactorial pathogenesis of ischaemic heart disease (IHD) includes 
a combination of environmental and genetic factors. Activation of inflammatory pathways 
is common in IHD, but mechanisms are still unknown. We and others have recently pro- 
posed that a polymorphism in the CD14 receptor gene of monocytes may be involved in 
IHD. In this study, we assessed whether other polymorphisms of genes codifying for pro- 
inflammatory mediators are involved in the inflammatory response observed in IHD. 
Methods: We studied 87 pts with Braunwald class IIIB unstable angina (Group 1) and 32 
pts with stable angina (Group 2). The following polymorphisms were detected by poly- 
merase chain reaction and restriction analysis: -174 G/C of IL6, Thr/Asn26 of TNF-~ and 
four polymorphisms of TNF-c~ (-376 G/A,-308 G/A,-244 G/A, -238 G/A). Genotype .and 
allele frequencies were correlated with C-reective protein (CRP) levels and IL-6 produc- 
tion by circulating monocyte in response to LPS-challenge (lng/ml for 4 hours). 
Results: Genotype and allele frequencies of the investigated polymorphisms were not 
different among groups. However, elevated levels of CRP (> 3mg/L) were observed in 
61% of the overall carriers of thr/thr genotype of TNF-[5 gene and 31% of thr/asn carders 
(p<0.05). Moreover, IL-6 production in response to LPS was higher in GG homozygotes 
of IL-6 gene than in GT heterozygotes (4.4 ng/ml vs 2.0 ng/ml; p<0.05). No correlation 
was found between CRP levels, IL-6 production and polymorphisms of TNF-c< gene, 
Conclusion: Our study suggests that in a polygenic and muItifactodal syndrome such as 
IHD, polymorphisms of TNF-~ and IL-6 genes, but not of TNF-m are related with an 
enhanced pro-inflammatory response. 
1025-36 The 894G T Polymorphism in the Endothelial Nitric 
Oxide Synthase Gene Influences Risk for Acute 
Myocardial Infarction Only in Subjects With Low Risk 
for Coronary Events 
Georae K. Anddkoooulos. Dimitri Richter, Dimitri Grammatopoulos, Sevasti Zervou, 
Michalis Zairis, Elias Karabinos, Antonis Pantazis, Dimitds Manolatos, Nikolaos 
Exadaktylos, Chdstodoulos Stefanadis, Stefanos Foussas, John Gialafos, Edward 
Hillhouse, Pavlos Toutouzas, Hippokration Hospital, Athens, Greece, Department of 
Biological Sciences, University of Warwick, Warwick, United Kingdom. 
Background: Homozygosity for the 894 G-T polymorphism in the Endothelial Nitdc 
Oxide Synthase(eNOS) gene, which encodes a Glu298-Asp substitution in eNOS, has 
been related to increased risk of acute myocardial infarction(AMI). We examined the role 
of this genetic variant in the pathogenesis of AMI in a relatively homogeneous, low coro- 
nary risk Caucasian population. Methods:1629 consecutive AMI patients (mean age 
62±13 years), enrolled into the GEMIG study were recruited on admission from 9 Cardiac 
Departments located in three cities. The GEMIG study is a multicentre prospective study, 
specifically designed to investigate the genetic background of ischemic heart disease in 
the Greek population. The control group (n=805, mean age 58±15 years) was derived 
from an epidemiological study that investigated the frequency of the same genetic vari- 
ants in a representative sample of the general adult population. Results:The frequency 
of the Asp298 variant was not significantly higher in AMI patients compared to controls 
(11.2 vs 10.4%, P=0.342). Adjustment for age and gender did not alter these results, but 
subgroup analysis showed an excess of homozygotes for the Asp298 allele among 
cases (12.9 vs 7.8%, P--0.033) in subjects with low risk for CAD (non-smokers without 
hypercholesterolemia). The Asp/Asp genotype was more frequent in younger patients 
with AMI and multivariate analYSiS showed that older age was independently associated 
with homozygocity for the Asp298 allele in AMI patients (RR=0.986, 95%C1=0.974-0.999, 
P=0.031) but not in controls (P=0.386). Univariate and multivariate analysis failed to 
demonstrate any relationship of the Asp298 variant with the extent of coronary artery dis- 
ease on angiography or with in-hospital mortality after AMI. Conclusion: The 894G-T 
polymorphism of the eNOS gene is related to individual risk of AMI in younger subjects 
with low coronary risk as estimated by the major conventional risk factors, but not in the 
total population. Given the key role of eNOS in the pathogenesis of ischemic heart dis- 
ease in humans, our results do emphasize the need for further evaluation of the possible 
influence of its genetic variants on the phenotypic expression of the disease. 
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1026-27 Continuing Evolution of Treatment Strategy and 
Outcome for Coronary Artery Disease: Observational 
Data 1986-2000 
Peter K. Smith. Eric R. Lilly, Robert H. Tuttle, Linda K. Shaw, Kerry L. Lee, Eric D. 
Peterson, Michael H. Sketch, Jr., Robert H, Jones, Duke Universi~ Durham, North 
Carolina. 
Background: Patients with significant (>=75% stenosis) coronary artery disease (CAD) 
were prospectively evaluated for all-cause mortality with adjustment for cardiac risk, co- 
morbidity and propensity to select one of three initial treatment options. 
Methods: 15,481 patients were treated between 1986 and 2000 and assigned to one of 
three groups based on the initial treatment strategy of either medical therapy (MED 
N=6862), percutaneous intervention (PCI N=6292) or coronary bypass (CABG N=5327). 
The results are stratified according to the extent of CAD into 9 groups ranging from one- 
vessel (no proximal LAD involvement, group 1) to three-vessel (with 95% proximal LAD 
obstruction, group 9) using the Duke CAD Index. 
Results: The initial treatment strategy has changed from 1986 (42%MED, 23%PCI, 
35%CABG) to 2000 (25%MED, 47%PC1, 28%CABG). Significantly improved survival in 
all treatment groups for all degrees of CAD has occurred over time. 
Conclusions: PCI and CABG continue to show significant longevity benefit compared to 
MED for all degrees of CAD. CABG remains the most robust and effective therapy for 
patients with multi-vessel disease and LAD involvement. CABG advantage over PCI 
begins with CAD more severe than group 5 (2-vessel CAD with 95% proximal LAD or 3- 
vessel CAD). Despite advances in PCI during the enrollment period, a developing advan- 
tage compared to CABG for more extensive CAD could not be demonstrated. 
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1026-28 Symptomatology and Presenting Electrocardiogarm 
Change With Age in Acute Coronary Syndromes 
Shlomo Stern, Solomon Behar, Valentina Boyko, Jonathan Lear, Shmual Gottlieb, Bikur 
Cholim Hospital, Jerusalem, Israel, Working Group on Intensive Cardiac Care, Israel 
Heart Society, Tel Hashomer, Israel 
Background: The presenting symptoms and electrocardiograph (ECG) changes identi- 
fied with acute coronary syndromes (ACS) are not uniform and may be influenced by 
several factors. We examined the influence of age on these manifestations. 
Methods: Data collected on 2133 consecutive ACS pts, 51% with ST-elevation (STE) and 
49% with non-STE (NSTE), in the framework of a national survey conducted in all 26 
hospitals in Israel during Feb-March 2000 were used in this analysis. The pts were 
divided in 3 age groups: <65 (n=974), 65-74 (n=500), and ->75 (n=639). 
Results: With advancing age, female gender, prior MI, previous angina, hypertension and 
Killip class >1 on admission became more frequent, whereas current smoking and hyper- 
lipidamia became less frequent (p for trend <0.0001, for all). The frequency of no chest 
pain/atypical symptoms on presentation increased with age for all ACS pts (14, 21, 32%, 
respectively, p for trend <0.0001). The corresponding figures in pts with STE were: 10, 
18, 27%, respectively; in pts with no STE were: 20, 24, 35%, respectively; and in pts with 
ST-depression (STD) were: 17, 25, 32%, respectively (p for trend <0.0001, for all). In 
ACS pts, STE on admission ECG decreased with advancing age (591 46, 42%, raspecac- 
tively), whereas STD gradually increased (14, 24, 28%, respectively; p for trend 
<0.0001 ). In multivariate analysis, independent predictors of no chest pain/atypical symp- 
toms on presentation (in decreasing order) were: age, history of heart failure, lack of past 
angina, diabetes and non-smoking. STE was negatively and independently associated 
with no chest pain/atypical symptoms on admission (OR=0.48; 95%CI 0.37-0.63). The 
use of acute repeffusion therapy (thrombolysis or primary PCI) declined with advancing 
age (39, 25, 14%, respectively; p for trend <0.0001). No chest pain/atypcial symptoms 
was an independent predictor of 30-day mortality (18.1 vs. 6.7%; OR=1.45; 95% CI 1.01 - 
2.06). 
Conclusions: In ACS pts with increasing age, no chest pain/atypical symptoms are 
increasing in frequency. In the older age groups, STE is becoming gradually less fre- 
quent, while STD is more frequent. These findings partially explain the lower use of rep- 
effusion therapy with advancing age. 
